Molecular Connections contributes Cell line Ontology to BioPortal

Molecular Connections contributes Cell line Ontology to BioPortal

Indian Life Sciences Informatics Company, Molecular Connections announced today that it has contributed cell line ontology to Bioportal

Indian Life Sciences Informatics Company, Molecular Connections announced today that it has contributed cell line ontology to Bioportal

Bangalore, India – Indian Life Sciences Informatics Company, Molecular Connections announced today that it has contributed cell line ontology to Bioportal

The cell line ontology developed in OBO format covers around 500 cell lines across various species, each linked in turn to major domains of interest for any cell line like the tissue of origin, disease association, if any and the species to which the cell line belongs. This has been developed as an extension of the sub class “cell line cell” which is a part of the major class “experimentally modified cell” of the Cell type [CL] ontology that already existed in OBO foundry. Disease ontology with which the cell line relates to has been exported from “Human Disease” [DOID] ontology and the organ/tissue details relate to the “Foundational model of anatomy” [FMA] ontology.

Ontologies act as a backbone for managing the Semantically indexed content. Molecular Connections speacializes in creation of customized ontology’s in the biomedical and chemistry areas.

GET IN TOUCH

Let's transform your workflow

Whether you're looking to automate processes, improve
quality, or scale operations, we're here to help.

Visit us

Bangalore • London • New York

Stay in the loop

Get the latest insights on AI, publishing innovation, and industry trends delivered to your inbox.
Enter your email
GET IN TOUCH

Let's transform your workflow

Whether you're looking to automate processes, improve
quality, or scale operations, we're here to help.

Visit us

Bangalore • London • New York

Stay in the loop

Get the latest insights on AI, publishing innovation, and industry trends delivered to your inbox.
Enter your email